MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Peverill RE et al. | Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII. | 2001 | Clin. Sci. | pmid:11410120 |
Ahmad ME et al. | Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro. | 2001 | Mutat. Res. | pmid:11423341 |
Moghissi KS | Symposium on scanning electron microscopy of fertility and infertility, Eighth World Congress of Fertility and Sterility, Buenos Aires, Argentina, November 1974. Endometrium and endosalpinx of women treated with microdose progestogens. | 1975 | J Reprod Med | pmid:1142361 |
pmid:11424084 | ||||
Kappus H and Bolt HM | Proceedings: Covalent protein binding of norethisterone and norethisterone-4,5-epoxide in liver microsomes. | 1975 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:1143488 |
Obruca A et al. | Ovarian function during and after treatment with the new progestagen Org 30659. | 2001 | Fertil. Steril. | pmid:11438328 |
Ventura P et al. | Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. | 2001 Jul-Aug | Menopause | pmid:11449082 |
Williams JG et al. | Metabolism of 4-3-H- and 4-14-C-17alpha-ethynylestradiol 3-methyl ether (mestranol) by women. | 1975 | Steroids | pmid:1145671 |
Yeung DL and Chan PL | Effects of a progestogen and a sequential type oral contraceptive on plasma vitamin A, vitamin E, cholesterol and triglycerides. | 1975 | Am. J. Clin. Nutr. | pmid:1146718 |
Goldzieher JW et al. | Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. | 1975 | Am. J. Obstet. Gynecol. | pmid:1146928 |